Back to results
US 11,208,386 B2Granted
Inhibitors of protein arginine deiminases (PADs) and methods of preparation and use thereof
AssigneeUniversity of Massachusetts
InventorsPaul R. Thompson, Aaron Muth, Venkataraman Subramanian
Life of this patent
Estimating the term…
Abstract
The invention provides novel inhibitors or inactivators of protein arginine deiminases, pharmaceutical compositions and methods of use thereof. The invention also relates to molecular probes based on such compounds and methods of use thereof.
Claims20
A compound having the structural formula (I),
- wherein
- each of Ra and Rb is independently selected from the group consisting of H, D and F;
- L is a bivalent hydrocarbyl linker, optionally with one or more carbon atoms replaced by a heteroatom selected from the group consisting of O, S and N;
- X is a halogen atom;
- Y is N, O or S;
- provided that when Y is S or O, its bonding to the adjacent carbons are single bonds;
- Z is N—R1, O or S;
- R1 is selected from the group consisting of:
- H, a C1-6 alkyl, OH, a C1-3 alkoxy, CF3, COCH3, or COCF3 groups;
- each of R2, R3, R4 and R5 is independently selected from the group consisting of:
- H, hydroxyl, halogen atom, C1-6 alkyl, C1-6 alkoxy, alkynyl, CF2Rc, or OCF2Rc groups, where Rc is H, F or alkyl, provided at least one of R2, R3, R4 and R5 is a group selected from the group consisting of hydroxyl, F, Cl, C1-6 alkyl, C1-6 alkoxy, alkynyl, CF2Rc and OCF2Rc groups;
- and
- R6 is a group comprising a cyclic alkyl or aryl moiety, or a pharmaceutically acceptable form thereof.
10 more elements
A compound having the structural formula (I),
- wherein
- each of Ra and Rb is independently selected from the group consisting of H, D and F;
- L is a bivalent hydrocarbyl linker, optionally with one or more carbon atoms replaced by a heteroatom selected from the group consisting of O, S and N;
- X is a halogen atom;
- Y is N, O or S;
- provided that when Y is S or O, its bonding to the adjacent carbons are single bonds;
- Z is N—R1, O or S;
- R1 is selected from the group consisting of:
- H, a C1-6 alkyl, OH, a C1-3 alkoxy, CF3, COCH3, or COCF3 groups;
- each of R2, R3, R4 and R5 is independently selected from the group consisting of:
- H, hydroxyl, halogen atom, C1-6 alkyl, C1-6 alkoxy, alkynyl, CF2Rc, or OCF2Rc groups, where Rc is H, F or alkyl;
- and
- R6 is a group selected from the group consisting of:
- wherein
- R7 is independently selected from the group consisting of H, C1-6 alkyl, C1-6 alkoxy, hydroxyl, halogen atoms, aryl, —COOR8, ethynyl, alkynyl, CF2Rc, and OCF2Rc, where Rc is H, F or alkyl;
- R8 is independently selected from the group consisting of H and C1-6 alkyl;
- and
- R9 is CH2, O, NH2 or S,
- or a pharmaceutically acceptable form thereof.
16 more elements
Dependencies are inferred from the claim text.